BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 29235868)

  • 1. Metabolomic Signature of Endometrial Cancer.
    Troisi J; Sarno L; Landolfi A; Scala G; Martinelli P; Venturella R; Di Cello A; Zullo F; Guida M
    J Proteome Res; 2018 Feb; 17(2):804-812. PubMed ID: 29235868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and Validation of a Serum Metabolomic Signature for Endometrial Cancer Screening in Postmenopausal Women.
    Troisi J; Raffone A; Travaglino A; Belli G; Belli C; Anand S; Giugliano L; Cavallo P; Scala G; Symes S; Richards S; Adair D; Fasano A; Bottigliero V; Guida M
    JAMA Netw Open; 2020 Sep; 3(9):e2018327. PubMed ID: 32986110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolomic prediction of endometrial cancer.
    Bahado-Singh RO; Lugade A; Field J; Al-Wahab Z; Han B; Mandal R; Bjorndahl TC; Turkoglu O; Graham SF; Wishart D; Odunsi K
    Metabolomics; 2017 Dec; 14(1):6. PubMed ID: 30830361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolomic biomarkers in cervicovaginal fluid for detecting endometrial cancer through nuclear magnetic resonance spectroscopy.
    Cheng SC; Chen K; Chiu CY; Lu KY; Lu HY; Chiang MH; Tsai CK; Lo CJ; Cheng ML; Chang TC; Lin G
    Metabolomics; 2019 Oct; 15(11):146. PubMed ID: 31664624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A metabolomics-based approach for non-invasive screening of fetal central nervous system anomalies.
    Troisi J; Landolfi A; Sarno L; Richards S; Symes S; Adair D; Ciccone C; Scala G; Martinelli P; Guida M
    Metabolomics; 2018 May; 14(6):77. PubMed ID: 30830338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urine and serum metabolomic analysis of endometrial cancer diagnosis and classification based on ultra-performance liquid chromatography mass spectrometry.
    Chen J; Lu H; Cao D; Sun J; Qi F; Liu X; Liu J; Yang J; Yu M; Zhou H; Cheng N; Wang J; Zhang Y; Peng P; Wang T; Shen K; Sun W
    Metabolomics; 2024 Jan; 20(1):18. PubMed ID: 38281200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel diagnostic biomarkers in endometrial cancer using targeted metabolomic profiling.
    Kozar N; Kruusmaa K; Dovnik A; Bitenc M; Argamasilla R; Adsuar A; Goswami N; Takač I; Arko D
    Adv Med Sci; 2021 Mar; 66(1):46-51. PubMed ID: 33360772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection and analysis on plasma metabolomics in patient with coronary heart disease of Xin-blood stasis syndrome pattern].
    Jian WX; Yuan ZK; Huang XP
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Jun; 30(6):579-84. PubMed ID: 20815270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A screening test proposal for congenital defects based on maternal serum metabolomics profile.
    Troisi J; Lombardi M; Scala G; Cavallo P; Tayler RS; Symes SJK; Richards SM; Adair DC; Fasano A; McCowan LM; Guida M
    Am J Obstet Gynecol; 2023 Mar; 228(3):342.e1-342.e12. PubMed ID: 36075482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A plasma metabolomic signature discloses human breast cancer.
    Jové M; Collado R; Quiles JL; Ramírez-Tortosa MC; Sol J; Ruiz-Sanjuan M; Fernandez M; de la Torre Cabrera C; Ramírez-Tortosa C; Granados-Principal S; Sánchez-Rovira P; Pamplona R
    Oncotarget; 2017 Mar; 8(12):19522-19533. PubMed ID: 28076849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Metabolomic Approach for the Screening of Endometrial Cancer: Validation from a Large Cohort of Women Scheduled for Gynecological Surgery.
    Troisi J; Mollo A; Lombardi M; Scala G; Richards SM; Symes SJK; Travaglino A; Neola D; de Laurentiis U; Insabato L; Di Spiezio Sardo A; Raffone A; Guida M
    Biomolecules; 2022 Sep; 12(9):. PubMed ID: 36139068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolomic and Lipidomic Profiling Identifies The Role of the RNA Editing Pathway in Endometrial Carcinogenesis.
    Altadill T; Dowdy TM; Gill K; Reques A; Menon SS; Moiola CP; Lopez-Gil C; Coll E; Matias-Guiu X; Cabrera S; Garcia A; Reventos J; Byers SW; Gil-Moreno A; Cheema AK; Colas E
    Sci Rep; 2017 Aug; 7(1):8803. PubMed ID: 28821813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometrium metabolomic profiling reveals potential biomarkers for diagnosis of endometriosis at minimal-mild stages.
    Li J; Guan L; Zhang H; Gao Y; Sun J; Gong X; Li D; Chen P; Liang X; Huang M; Bi H
    Reprod Biol Endocrinol; 2018 Apr; 16(1):42. PubMed ID: 29712562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening and verifying endometrial carcinoma diagnostic biomarkers based on a urine metabolomic profiling study using UPLC-Q-TOF/MS.
    Shao X; Wang K; Liu X; Gu C; Zhang P; Xie J; Liu W; Sun L; Chen T; Li Y
    Clin Chim Acta; 2016 Dec; 463():200-206. PubMed ID: 27784637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic signatures of esophageal cancer: NMR-based metabolomics and UHPLC-based focused metabolomics of blood serum.
    Zhang X; Xu L; Shen J; Cao B; Cheng T; Zhao T; Liu X; Zhang H
    Biochim Biophys Acta; 2013 Aug; 1832(8):1207-16. PubMed ID: 23524237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolomics in endometrial cancer diagnosis: A systematic review.
    Raffone A; Troisi J; Boccia D; Travaglino A; Capuano G; Insabato L; Mollo A; Guida M; Zullo F
    Acta Obstet Gynecol Scand; 2020 Sep; 99(9):1135-1146. PubMed ID: 32180221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A validated metabolomic signature for colorectal cancer: exploration of the clinical value of metabolomics.
    Farshidfar F; Weljie AM; Kopciuk KA; Hilsden R; McGregor SE; Buie WD; MacLean A; Vogel HJ; Bathe OF
    Br J Cancer; 2016 Sep; 115(7):848-57. PubMed ID: 27560555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A metabolomic signature of FIGO stage I and II endometrial cancer.
    Gu M; Chen X; Sun Y; Wang L; Shu H; Qian C
    Neoplasma; 2021 Nov; 68(6):1283-1291. PubMed ID: 34689564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD44, TGM2 and EpCAM as novel plasma markers in endometrial cancer diagnosis.
    Torres A; Pac-Sosińska M; Wiktor K; Paszkowski T; Maciejewski R; Torres K
    BMC Cancer; 2019 Apr; 19(1):401. PubMed ID: 31035965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum metabolomic profiling of prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial.
    Huang J; Mondul AM; Weinstein SJ; Koutros S; Derkach A; Karoly E; Sampson JN; Moore SC; Berndt SI; Albanes D
    Br J Cancer; 2016 Oct; 115(9):1087-1095. PubMed ID: 27673363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.